Close
Digital Health & Ai Innovation summit 2026
Medical Taiwan 2026

Cardiff University develops AI tool to detect Type 1 diabetes in childhood

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media PackNow

– Book a Conference Call

Leave Message for Us to Get Back

Related stories

UK Medical Device Testing Jumps 17%,...

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse...

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK...

Teleradiology provider Medica Group has agreed to integrate Axon...

Researchers from Cardiff University have developed a tool that uses AI technology to predict whether certain children may go on to develop Type 1 diabetes and could lead to earlier diagnosis.

Funding from Diabetes UK, enabled researchers at Cardiff University to use AI technology and electronic health records for children to develop a predictive tool. Data from one million children was used to train the tool to spot patterns in GP records that could highlight a potential case of type 1 diabetes.

The team tested different combinations of factors marked in GP records, such as urinary infections, bedwetting, family history and being prescribed antibiotics, to learn which factors could best predict a diagnosis of the condition.

To test their methods, they then used the tool on 1.5million children who had already received a type 1 diagnosis.

They determined that when they set the level to 10% (where 1 in 10 children consulting with a GP would raise an alert) the tool was successful in identifying 75 per cent of children who would go on to get a diabetes diagnosis within 90 days.

The use of AI would allow children to receive a diagnosis 11 days earlier than they had, on average. This head start means they have earlier access to life-saving insulin therapy, and the risk of diabetic ketoacidosis (DKA) can be significantly reduced.

Dr Julia Townson, senior research fellow at Cardiff University’s centre for trials research, said: “We are now looking to see how this tool might work with primary care computer systems. If possible, this would enable us to carry out a feasibility study to assess the acceptability of the tool with GPs. Use of the tool may be some years away yet – but we are hopeful it will provide a vital new avenue for early diagnosis of diabetes which could save lives.”

Latest stories

Related stories

UK Medical Device Testing Jumps 17%, AI and Neurotech Lead

Clinical investigations of medical devices in the UK reached...

Medtronic Secures FDA PMA for Infuse Bone Graft in TLIF

Medtronic announced that it has secured FDA premarket approval...

Medica Axon Diagnostics Merger Expands UK Clinical Reporting

Teleradiology provider Medica Group has agreed to integrate Axon...

Sutter Health Integrates AI Decision Support in Epic EHR

Sutter Health is integrating artificial intelligence-powered decision support technology...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

Leave Message for Us to Get Back

Translate »